FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969210291> ?p ?o ?g. }

• W2969210291 endingPage "11208" @default.
• W2969210291 startingPage "11200" @default.
• W2969210291 abstract "Multidrug resistance is a major cause of failure in the clinical cancer therapy, in which the overexpression of P-glycoprotein (P-gp) plays a crucial role. Herein, we fabricate a theranostic nanoprobe with the function of simultaneous detection and inhibition of P-gp to diagnose and combat multidrug-resistant cancer in vitro and in vivo. For constructing the nanoprobe, elacridar modified quantum dots (QDs-Ela), acting as a gatekeeper, are grafted onto the doxorubicin (DOX) loaded, folic acid (FA) decorated mesoporous silica nanoparticles (MSNs). Upon targeted uptake by multidrug-resistant cancer cells, Bel-7402/ADR are used as a model, the acidic environment results in QDs-Ela removal from the nanoprobe, and subsequent DOX release. The removed QDs-Ela could specifically combine with P-gp in the cancer cell membrane and inhibit their active sites, which prevents the efflux of intracellular DOX and increases the retention of DOX. Another way, the fluorescence intensity of the binding QDs-Ela quantifies the P-gp expression level. Subsequently, in vitro and in vivo experiments both demonstrate the enhanced multidrug-resistant cancer therapy efficacy, i.e., nanoprobe has 10 times better curative effect than free DOX. In addition, due to the conjugation of FA, the nanoprobe exhibits a selective cell targeting ability to Bel-7402/ADR cells. This nanoplatform paves a new avenue for the accurate treatment of multidrug-resistant cancers." @default.
• W2969210291 created "2019-08-22" @default.
• W2969210291 creator A5022907497 @default.
• W2969210291 creator A5023696126 @default.
• W2969210291 creator A5047784692 @default.
• W2969210291 creator A5049108933 @default.
• W2969210291 creator A5049252104 @default.
• W2969210291 creator A5075638886 @default.
• W2969210291 creator A5082798064 @default.
• W2969210291 date "2019-08-12" @default.
• W2969210291 modified "2023-10-14" @default.
• W2969210291 title "Theranostic Nanoprobe Mediated Simultaneous Monitoring and Inhibition of P-Glycoprotein Potentiating Multidrug-Resistant Cancer Therapy" @default.
• W2969210291 cites W147439079 @default.
• W2969210291 cites W1868754155 @default.
• W2969210291 cites W1968931590 @default.
• W2969210291 cites W1970888796 @default.
• W2969210291 cites W1973906087 @default.
• W2969210291 cites W1980873645 @default.
• W2969210291 cites W1981710788 @default.
• W2969210291 cites W2001818671 @default.
• W2969210291 cites W2009098269 @default.
• W2969210291 cites W2015869781 @default.
• W2969210291 cites W2015996393 @default.
• W2969210291 cites W2016066728 @default.
• W2969210291 cites W2025106411 @default.
• W2969210291 cites W2029439561 @default.
• W2969210291 cites W2042779590 @default.
• W2969210291 cites W2057256078 @default.
• W2969210291 cites W2062541508 @default.
• W2969210291 cites W2077085855 @default.
• W2969210291 cites W2095651642 @default.
• W2969210291 cites W2108322397 @default.
• W2969210291 cites W2120035328 @default.
• W2969210291 cites W2126371858 @default.
• W2969210291 cites W2140901374 @default.
• W2969210291 cites W2589069620 @default.
• W2969210291 cites W2601251562 @default.
• W2969210291 cites W2606691659 @default.
• W2969210291 cites W2729924380 @default.
• W2969210291 cites W2754130120 @default.
• W2969210291 cites W2770163175 @default.
• W2969210291 cites W2793067512 @default.
• W2969210291 cites W2796145557 @default.
• W2969210291 doi "https://doi.org/10.1021/acs.analchem.9b02118" @default.
• W2969210291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31403276" @default.
• W2969210291 hasPublicationYear "2019" @default.
• W2969210291 type Work @default.
• W2969210291 sameAs 2969210291 @default.
• W2969210291 citedByCount "17" @default.
• W2969210291 countsByYear W29692102912019 @default.
• W2969210291 countsByYear W29692102912020 @default.
• W2969210291 countsByYear W29692102912021 @default.
• W2969210291 countsByYear W29692102912022 @default.
• W2969210291 countsByYear W29692102912023 @default.
• W2969210291 crossrefType "journal-article" @default.
• W2969210291 hasAuthorship W2969210291A5022907497 @default.
• W2969210291 hasAuthorship W2969210291A5023696126 @default.
• W2969210291 hasAuthorship W2969210291A5047784692 @default.
• W2969210291 hasAuthorship W2969210291A5049108933 @default.
• W2969210291 hasAuthorship W2969210291A5049252104 @default.
• W2969210291 hasAuthorship W2969210291A5075638886 @default.
• W2969210291 hasAuthorship W2969210291A5082798064 @default.
• W2969210291 hasConcept C121608353 @default.
• W2969210291 hasConcept C12554922 @default.
• W2969210291 hasConcept C126322002 @default.
• W2969210291 hasConcept C133936738 @default.
• W2969210291 hasConcept C150903083 @default.
• W2969210291 hasConcept C155672457 @default.
• W2969210291 hasConcept C16387964 @default.
• W2969210291 hasConcept C171250308 @default.
• W2969210291 hasConcept C185592680 @default.
• W2969210291 hasConcept C192562407 @default.
• W2969210291 hasConcept C200082930 @default.
• W2969210291 hasConcept C202751555 @default.
• W2969210291 hasConcept C207001950 @default.
• W2969210291 hasConcept C2776694085 @default.
• W2969210291 hasConcept C2778707650 @default.
• W2969210291 hasConcept C2781303535 @default.
• W2969210291 hasConcept C501593827 @default.
• W2969210291 hasConcept C502942594 @default.
• W2969210291 hasConcept C55493867 @default.
• W2969210291 hasConcept C71924100 @default.
• W2969210291 hasConcept C79879829 @default.
• W2969210291 hasConcept C86803240 @default.
• W2969210291 hasConcept C96232424 @default.
• W2969210291 hasConcept C98274493 @default.
• W2969210291 hasConceptScore W2969210291C121608353 @default.
• W2969210291 hasConceptScore W2969210291C12554922 @default.
• W2969210291 hasConceptScore W2969210291C126322002 @default.
• W2969210291 hasConceptScore W2969210291C133936738 @default.
• W2969210291 hasConceptScore W2969210291C150903083 @default.
• W2969210291 hasConceptScore W2969210291C155672457 @default.
• W2969210291 hasConceptScore W2969210291C16387964 @default.
• W2969210291 hasConceptScore W2969210291C171250308 @default.
• W2969210291 hasConceptScore W2969210291C185592680 @default.
• W2969210291 hasConceptScore W2969210291C192562407 @default.
• W2969210291 hasConceptScore W2969210291C200082930 @default.
• W2969210291 hasConceptScore W2969210291C202751555 @default.

• next